Chen et al.41 reported that fenofibrate, a common drug used to treat severe hypertriglyceridemia and mixed dyslipidemia, altered glucose and lipid metabolism, inhibited gastric cancer cell proliferation, and promoted apoptotic gastric cancer cells through PPARα. This evidence concerns the gene PPARA and hypertriglyceridemia.